Enzymology of the reduction of the potent benzotriazine-di-n-oxide hypoxic cell cytotoxin SR 4233 (win 59075) by NAD(P)H: (Quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from walker 256 rat tumour cells
Authors:
- 22 January 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (2) , 167-174
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- SR 4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell culturesBritish Journal of Cancer, 1991
- Reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and the induction of unscheduled DNA synthesis in rat and human derived cell linesCarcinogenesis, 1990
- Enzymology of the reductive bioactivation of SR 4233Biochemical Pharmacology, 1990
- Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxinsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233Radiotherapy and Oncology, 1988
- Molecular mechanisms for the hypoxiadependent activation of 3-amino-1,2,4-benzotriazine-1, 4-dioxide (SR 4233)Biochemical Pharmacology, 1988
- Identification of two major reduction products of the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxideBiochemical Pharmacology, 1986
- SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cellsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986
- Use of quinones in brain‐tumor therapy: Preliminary results of preclinical laboratory investigationsJournal of Toxicology and Environmental Health, 1985
- The hypoxic tumor cell: A target for selective cancer chemotherapyBiochemical Pharmacology, 1980